Valuation: AstraZeneca PLC

Market Cap 285B 249B 229B 214B 405B 27,164B 412B 2,757B 1,068B 13,324B 1,071B 1,048B 45,909B P/E 2026 *
22.9x
P/E 2027 * 20.1x
Enterprise Value 305B 266B 244B 228B 432B 28,998B 439B 2,943B 1,140B 14,223B 1,144B 1,119B 49,009B EV / Sales 2026 *
4.81x
EV / Sales 2027 * 4.44x
Free-Float
96.63%
Yield 2026 *
1.81%
Yield 2027 * 1.91%
1 day+5.19%
1 week+3.39%
Current month+3.11%
1 month+10.02%
3 months-5.08%
6 months+6.96%
Current year+5.42%
1 week 13,838
Extreme 13838
14,686
1 month 11,232
Extreme 11232
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,112
Extreme 10112
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+4.94%+3.39%+39.92%+40.14% 285B
+1.44%+7.01%+54.86%+161.54% 1,063B
+2.71%+6.30%+67.33%+59.35% 611B
+3.37%+6.37%+35.59%+91.57% 444B
+4.17%-0.96%+26.12%+20.22% 324B
+2.42%+1.60%+30.06%+44.59% 283B
+2.47%+5.18%-24.80%-38.67% 219B
+2.93%+5.52%+25.41%+65.45% 195B
+3.52%+5.28%+16.93%+69.96% 156B
+1.61%+2.58%-4.11%-33.75% 136B
Average +3.01%+2.28%+26.73%+48.04% 371.68B
Weighted average by Cap. +2.71%+3.91%+39.08%+77.99%

Financials

2026 *2027 *
Net sales 63.33B 55.34B 50.82B 47.39B 89.84B 6,029B 91.35B 612B 237B 2,957B 238B 233B 10,190B 67.02B 58.56B 53.78B 50.15B 95.07B 6,380B 96.68B 647B 251B 3,130B 252B 246B 10,784B
Net income 12.47B 10.9B 10.01B 9.33B 17.69B 1,187B 17.99B 120B 46.69B 582B 46.82B 45.81B 2,006B 14.01B 12.24B 11.24B 10.48B 19.87B 1,333B 20.2B 135B 52.44B 654B 52.59B 51.45B 2,254B
Net Debt 19.27B 16.84B 15.46B 14.42B 27.33B 1,834B 27.79B 186B 72.14B 900B 72.34B 70.77B 3,100B 12.02B 10.51B 9.65B 9B 17.06B 1,145B 17.34B 116B 45.02B 561B 45.15B 44.17B 1,935B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-02 GBX 14,538.00 +4.94% 2,042,987
26-07-01 GBX 13,854.00 -1.74% 1,804,499
26-06-30 GBX 14,100.00 -1.38% 2,513,351
26-06-29 GBX 14,298.00 -0.14% 1,883,887
26-06-26 GBX 14,318.00 +1.82% 3,946,268
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
183.97USD
Average target price
218.03USD
Spread / Average Target
+18.52%

Quarterly revenue - Rate of surprise